Corporación Bonima

Corporación Bonima is a leading pharmaceutical manufacturer and distributor headquartered in El Salvador, serving the Central American and Caribbean markets. Founded in 1973 and acquired by the Costa Rican pharmaceutical group Stein Corp in 2014, the company operates a sophisticated production facility dedicated to high-quality generic and over-the-counter medications. Its extensive product portfolio covers critical therapeutic areas including cardiology, gastroenterology, respiratory health, and infectious diseases. Bonima is recognized for its robust manufacturing capabilities, maintaining strict adherence to Good Manufacturing Practices (GMP) to ensure the safety and efficacy of its treatments. The company plays a vital role in the regional healthcare ecosystem by providing affordable access to essential medicines and offering contract manufacturing services to international partners.